Li, T., He, X., Tao, W., Zhang, R., He, Q., Gong, H., . . . He, Y. (2024). Development of membrane-targeting TPP+-chloramphenicol conjugates to combat methicillin-resistant staphylococcus aureus (MRSA) infections. European journal of medicinal chemistry, 264, 115973-115985. https://doi.org/10.1016/j.ejmech.2023.115973
Chicago Style (17th ed.) CitationLi, Tao, et al. "Development of Membrane-targeting TPP+-chloramphenicol Conjugates to Combat Methicillin-resistant Staphylococcus Aureus (MRSA) Infections." European Journal of Medicinal Chemistry 264 (2024): 115973-115985. https://doi.org/10.1016/j.ejmech.2023.115973.
MLA (9th ed.) CitationLi, Tao, et al. "Development of Membrane-targeting TPP+-chloramphenicol Conjugates to Combat Methicillin-resistant Staphylococcus Aureus (MRSA) Infections." European Journal of Medicinal Chemistry, vol. 264, 2024, pp. 115973-115985, https://doi.org/10.1016/j.ejmech.2023.115973.